$5.26

-0.09 (-1.68%)

Weekly Expected Move ±6.2%

$5 $5 $5 $6 $6

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 28 · $388.8M mcap · 66M float · 0.276% daily turnover · Short 20% of daily vol

Income Trends

Revenue

$836M -4.9% ▼

Gross Profit

$429M -3.4% ▼

Operating Income

$95M +140.2% ▲

Net Income

-$262M +23.2% ▲

EPS (Diluted)

$-0.72 +24.2% ▲

EBITDA

$222M +335.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2025
Revenue	$836M
YoY Growth	-4.9%
Cost of Revenue	$407M
Gross Profit	$429M
Gross Margin	51.3%
R&D Expenses	$0
SG&A Expenses	$333M
Operating Expenses	$333M
Operating Income	$95M
Operating Margin	11.4%
Interest Expense	$55M
Income Before Tax	-$169M
Tax Expense	$93M
Net Income	-$262M
Net Margin	-31.4%
EPS (Diluted)	$-0.72
EBITDA	$222M
Shares Outstanding	363M

Line Item	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$201M	$210M	$205M	$212M
Cost of Revenue	$111M	$101M	$112M	$118M
Gross Profit	$89M	$109M	$93M	$100M
Gross Margin	44.5%	51.8%	45.2%	46.9%
R&D Expenses	$0	$0	$0	$0
SG&A Expenses	$75M	$85M	$81M	$88M
Operating Expenses	$75M	$85M	$80M	$97M
Operating Income	$15M	$24M	$13M	$7M
Operating Margin	7.2%	11.2%	6.3%	3.3%
Interest Expense	$13M	$13M	$12M	$11M
Income Before Tax	-$15M	-$175M	-$6M	-$10M
Tax Expense	$28M	$11M	$11M	$3M
Net Income	-$43M	-$186M	-$18M	-$13M
Net Margin	-21.6%	-88.8%	-8.6%	-6.2%
EPS (Diluted)	$-0.12	$-2.55	$-0.24	$-0.18
EBITDA	$32M	$53M	$45M	$39M
Shares Outstanding	362M	73M	73M	73M

VRNO OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet